pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Patients struggle to opt out of MyChart data sharing, facing notary and endless hurdles

Oct 15, 2026·read at STAT ↗Negative

An opinion piece highlights how MyChart users who want to stop sharing their health information encounter a maze of requirements. The author describes needing a notary, multiple phone calls, unanswered emails and even a personal visit to complete the opt-out.

The article cites Dr. Shira Fischer, who in 2022 sought a speech-pathology appointment for her child. The clinic’s consent form demanded that the session be recorded for training purposes, which the family refused, prompting them to find another provider.

The piece argues that many doctors across the United States now tell patients that access to their data by tens of thousands of hospitals and clinics is a condition for receiving care. Consent forms are often written broadly, giving providers extensive rights to use patient information.

Overall, the author portrays the opt-out process as maddening and opaque, raising concerns about patient autonomy and data privacy.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: MyChart said I could opt out of sharing my health data. Figuring out how was maddening”

read at STAT ↗
4,860 words · retrieved 53m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING2JOURNEYRADIUSUltragenyx Pharmaceutical Inc.University of California San Francisco
topics
Drug Shortage2Breast CancerMicrobiomeOncologyRare DiseaseVaccine

related stories

  • 5d agoCaribou layoffs could wipe out 90% of staffBioSpace
  • Dec 22Fierce Biotech Fundraising Tracker '26: Soufflé cooks up $135M; Matchpoint makes $150MFierce Biotech
  • 1d agoHelen Branswell, whose reporting on infectious diseases and public health drew acclaim, dies at 69STAT
  • 6d agoThe Nobel boys club (again)STAT
  • Oct 5STAT+: Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine marketSTAT